Quiet on the insider front: nobody at Gladstone Alternative Income Fund bought or sold GAIAX shares at market prices this past year.
No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
Quiet on the insider front: nobody at Gladstone Alternative Income Fund bought or sold GAIAX shares at market prices this past year.
No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Dec 13, 2024 | Dellafiora John | Executive Officer | Buy | 300 | $10.00 | $3K | SEC |
| Dec 10, 2024 | Sateri John | President | Buy | 10,000 | $10.00 | $100K | SEC |
| Dec 10, 2024 | LiCalsi Michael | Executive Officer | Buy | 1,500 | $10.00 | $15K | SEC |
| Dec 10, 2024 | Smith Jennifer A | Executive Officer | Buy | 300 | $10.00 | $3K | SEC |
| Dec 10, 2024 | MALESARDI MICHAEL J | CFO | Buy | 1,000 | $10.00 | $10K | SEC |
| Dec 10, 2024 | GLADSTONE DAVID | CEO | Buy | 10,000 | $10.00 | $100K | SEC |
| Dec 10, 2024 | GLADSTONE DAVID | CEO | Buy | 230,000 | $10.00 | $2.3M | SEC |
| Dec 10, 2024 | GLADSTONE DAVID | CEO | Buy | 10,000 | $10.00 | $100K | SEC |
There were no open-market insider trades in GAIAX in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
No congressional trades in GAIAX were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).